JPRN-UMIN000025056已完成未知
The effect of denosmab on osteoporosis related to Parkinson's disease and glucocorticoid-induced osteoporosis - The effect of denosmab on neurological disorders
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Current or previous use of denosumab (2)Patients with renal insufficiency (CCr <30ml/min) (3)Patients with hypocalcemia(serum calcium<8.4mg/dl) (4)Female patients who are pregnant, trying to become pregnant or nursing (lactating) an infant
研究者
相似试验
已完成
不适用
Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritisRheumatoid ArthritisJPRN-UMIN000042107Department of Orthopedic Surgery, Tohoku University Graduate School of Medicine200
已完成
不适用
Effect of Denosumab and Alendronate on osteoporosis in hemodialysis patients :a randomized controlled trialosteoporosisJPRN-UMIN000022985Makita general hospital80
进行中（未招募）
不适用
A clinical trial to find out whether a medication, called denosumab, has an effect on the bone surrounding a hip joint replacementEUCTR2011-000541-20-GBSheffield Teaching Hospitals NHS Foundation Trust30
招募中
不适用
Effects of denosumab for bone resorption in the femur after total hip arthroplastypatients treated with primary total hip arthroplastyJPRN-UMIN000028169Yokohama City University80
已完成
不适用
The effect of denosumab for the treatment of osteoporosis in hemodialysis patientsOsteoporosisJPRN-UMIN000014458Saiseikai Kumamoto Hospital40